Home > News > avVaa World Health Care Products Launches New Clinical Trial Studies
December 26th, 2006
avVaa World Health Care Products Launches New Clinical Trial Studies
Abstract:
Alden continued, "The results of a recent German trial comparing NEUROSKIN Forte (Psoriasis) and NEUROSKIN Mild will be published as part of that ad campaign and have already been presented at the New Jersey Technology Council conference on nanotechnology that we attended this past summer."
Source:
yahoo.com
Bookmark:
| Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Human Interest/Art
Drawing data in nanometer scale September 30th, 2022
Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022
Graphene nanotubes revolutionize touch screen use for prosthetic hands August 3rd, 2021
JEOL Announces 2020 Microscopy Image Grand Prize Winners January 7th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||